In the post-acute phase of pneumonia, PαS MSC-treated animals exhibited significantly reduced respiratory IL-17+ CD4+ T cells and IFN-γ+ CD4+ T cells. The gene discussed is CD4; the disease is susceptibility to pneumonia measurement.